News Daily News Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib Caitlin E. Cox September 14, 2011
News Daily News Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran L.A. McKeown September 13, 2011
News Industry News FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation September 08, 2011
News Daily News Medical Therapy Alone Superior to Stenting for Intracranial Stenosis September 07, 2011
News Conference News ESC Congress 2011: Drugs, Devices Work Together Caitlin E. Cox September 06, 2011
News Daily News Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients L.A. McKeown August 16, 2011
News Daily News ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients Caitlin E. Cox August 10, 2011
News Daily News Commentary Authors Urge Improvements to Device Approval Process Caitlin E. Cox July 20, 2011
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011
News Industry News Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device May 18, 2011
News Industry News Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech March 02, 2011
News Daily News Dabigatran Recommended as Alternative to Warfarin in A-fib Patients Jason Kahn February 13, 2011